FrancophonIA/ELRC3.0 huggingface dataset:
English: The recommended dose is 30 mg once daily for 2 weeks.
Danish: Den anbefalede dosis er 30 mg én gang daglig i 2 uger.
English: BATCH NUMBER BN
Danish: BATCH NUMMER
English: Peripheral edema.
Danish: Perifert ødem.
English: If required, the dose can be increased to 1 capsule once daily (equivalent to 30 mg lansoprazole).
Danish: Hvis det er påkrævet, kan dosis øges til 1 kapsel én gang daglig (svarende til 30 mg lansoprazol).
English: In patients with mildly impaired liver function, a daily dose of 30 mg lansoprazole should not be exceeded.
Danish: Hos patienter med let nedsat leverfunktion, bør en dosis på 30 mg lansoprazol ikke overskrides.
English: If required, the dose can be increased to 2 capsules once daily (equivalent to 30 mg lansoprazole).
Danish: Hvis det er påkrævet, kan dosis øges til 2 kapsler én gang daglig (svarende til 30 mg lansoprazol).
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each gastro-resistant capsule contains 30 mg lansoprazole
Danish: ANGIVELSE AF AKTIV SUBSTANS(ER) Hver gastro-resistent kapsel indeholder 30 mg lansoprazol
English: The recommended dose is 30 mg once daily for 4 weeks.
Danish: Den anbefalede dosis er 30 mg én gang daglig i 4 uger.
English: Increase in liver enzyme levels.
Danish: Øgning af niveauerne for leverenzymer.
English: INFORMATION IN BRAILLE < Lansoprazol-CT 15 mg > [to be completed nationally]
Danish: INFORMATION I BRAILLE < Lansoprazol-CT 15 mg >
English: Prevention of a recurrence of inflammation of the gullet due to reflux of stomach acid The recommended dose is 15 mg lansoprazole once daily.
Danish: Forhindring af en gentagelse af inflammation af spiserøret grundet refluks af mavesyre Den anbefalede dosis er 15 mg lansoprazol.
English: A daily dose of 30 mg should not be exceeded.
Danish: En daglig dosis på 30 mg bør ikke overskrides.
English: (See Section 4.2 Posology and Method of Administration)
Danish: 4.2 Dosering og indgivelsesmåde)
English: Prevention of a recurrence of inflammation of the gullet due to reflux of stomach acid The recommended dose is 1 capsule once daily (equivalent to 15 mg lansoprazole).
Danish: Forhindring af en gentagelse af inflammation af spiserøret grundet refluks af mavesyre Den anbefalede dosis er 1 kapsel én gang daglig (svarende til 15 mg lansoprazol).
English: The recommended initial dosage is 4 capsules once daily (equivalent to 60 mg lansoprazole).
Danish: Den anbefalede indledningsdosis er 4 kapsler én gang daglig (svarende til 60 mg lansoprazol).
English: • amoxicillin, 500 mg three times daily, + metronidazole, 400 mg three times daily (advisable when clarithomycin resistance is likely)
Danish: • amoxicillin, 500 mg tre gange dagligt, + metronidazol, 400 mg tre gange dagligt (tilrådeligt,
English: Musculoskeletal and connective tissue disorders
Danish: Muskuloskeleta le og bindevævs forstyrrelser
English: The recommended dose is 30 mg lansoprazole 2 times daily for one week in combination with one of the following three combinations: a) amoxicillin 1 g twice daily + clarithromycin 500 mg twice daily, b) clarithromycin 250 mg twice daily + metronidazole 400-500 mg twice daily, c) amoxicillin 1 g twice daily + metronidazole 400-500 mg twice daily.
Danish: a) amoxicillin 1 g to gange daglig + clarithromycin 500 mg to gange daglig b) clarithromycin 250 mg to gange daglig + metronidazol 400-500 mg to gange daglig c) amoxicillin 1 g to gange daglig + metronidazol 400-500 mg to gange daglig.
English: First line therapy should be with triple therapy using a proton pump inhibitor or ranitidine bismuth citrate, combined with clarithromycin (500 mg twice daily) and amoxicillin (1 g twice daily) or metronidazole (500 twice daily).
Danish: Det blev påpeget, at behandlingen var en pakke, som tager hensyn til førstevalgs- og andetvalgseradikationsbehandlinger under et. Førstevalgsbehandlingen bør være en tredobbelt behandling med en protonpumpe-hæmmer eller ranitidinvismutsitrat kombineret med clarithromycin (500 mg to gange dagligt) og amoxicillin (1 g to gange dagligt) eller (500 to gange dagligt).
English: The capsules may be emptied, but the contents may not be chewed or ground.Concomitantly taken food slows down and reduces the absorption of lansoprazole.
Danish: Kapslerne kan tømmes, men indholdet må ikke tygges eller stødes.
English: What Lansoprazol-CT contains
Danish: Hvad indeholder Lansoprazol-CT
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each gastro-resistant capsule contains 15 mg lansoprazole
Danish: ANGIVELSE AF AKTIV SUBSTANS(ER) EHver gastro-resistennt kapsel indeholder 15 mg lansoprazol
English: Treatment of inflammation of the gullet due to reflux of stomach acid The recommended dose is 2 capsules once daily (equivalent to 30 mg lansoprazole) for 4 weeks.
Danish: Behandling af inflammation af spiserøret grundet refluks af mavesyre Den anbfalede dosis er 2 kapsler én gang daglig (svarende til 30 mg lansoprazol) i 4 uger.
English: Muscle and joint pain.
Danish: Muskel- og ledsmerter.
English: Treatment of inflammation of the gullet due to reflux of stomach acid The recommended dose is 1 capsule once daily (equivalent to 30 mg lansoprazole) for 4 weeks.
Danish: Behandling af inflammation af spiserøret grundet refluks af mavesyre Den anbfalede dosis er 1 kapsel én gang daglig (svarende til 30 mg lansoprazol) i 4 uger.
English: Lansoprazol CT-Arzneimittel 30 mg 30 mg Gastro-resistant capsule, hard Oral use
Danish: Lansoprazol CT-Arzneimittel 30 mg 30 mg gastro-resistent kapsel, hård Oral anvendelse
English: Marketing Authorisation Holder: ratiopharm GmbH, Graf-Arco-Strasse 3, D-89070 Ulm, Germany
Danish: Indehaver af markedsføringsilladelsen: ratiopharm GmbH, Graf-Arco-Str. 3, D-89079 Ulm, Tyskland
English: Lansoprazol-CT 15 mg Hartkapseln 15 mg Gastro-resistant capsule, hard Oral use
Danish: Lansoprazol-CT 15 mg Hartkapseln 15 mg gastro-resistent kapsel, hård Oral anvendelse
English: Lansoprazol-CT 30 mg Hartkapseln 30 mg Gastro-resistant capsule, hard Oral use
Danish: Lansoprazol-CT 30 mg Hartkapseln 30 mg gastro-resistent kapsel, hård Oral anvendelse
English: Lansoprazol CT-Arzneimittel 15 mg 15 mg Gastro-resistant capsule, hard Oral use
Danish: Lansoprazol CT-Arzneimittel 15 mg 15 mg gastro-resistent kapsel, hård Oral anvendelse
English: dryness of the throat or mouth, loss of appetite.
Danish: Ualmindelig: Tørhed i mund og svælg, appetitløshed.
English: muscle and joint pain
Danish: Muskel- og ledsmerter
English: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-CT and associated names (see Annex I) 15 mg , gastro-resistant capsules, hard > [see Annex I - to be completed nationally]
Danish: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-CT og tilknyttede navne (se Bilag I) 15 mg gastro-resistente hårde kapsler > [se Bilag I - udfyldes nationalt]
English: < Lansoprazol-CT and associated names (see Annex I) 15 mg , gastro-resistant capsules, hard > < Lansoprazol-CT and associated names (see Annex I) 30 mg , gastro-resistant capsules, hard >
Danish: LÆGEMIDLETS NAVN < Lansoprazol-CT og tilknyttede navne (se Bilag I) 15 mg gastro-resistent hård kapsel> < Lansoprazol-CT og tilknyttede navne (se Bilag I) 30 mg gastro-resistent hård kapsel >
English: the CHMP has recommended the granting of the Marketing Authorisations for which the Summary of Product Characteristics, labelling and package leaflet are set out in Annex III for Lansoprazol AbZPharma and associated names (see Annex I).
Danish: ¾ det af ansøgeren foreslåede produktresumé er blevet vurderet på grundlag af den forelagte dokumentation og den faglige drøftelse i udvalgetanbefaler CHMP, at der udstedes markedsføringstilladelser med ændringer af produktresuméet for Lansoprazol CT-Arzneimittel og de tilknyttede navne.
English: Tacrolimus (medicine used to prevent rejection of a transplant) Simultaneous use of lansoprazole causes a rise in the plasma concentrations of tacrolimus.
Danish: Tacrolimus (lægemiddel, der anvendes til at forhindre afstødning af et transplantat).
English: Phenytoin (medicine used in the treatment of fits and irregularities of heart rhythm) If there is simultaneous use of lansoprazole, a dose reduction of phenytoin may be necessary.
Danish: Hvis der er samtidig brug af lansoprazol, kan en dosisreduktion af fenytoin blive nødvendig.
English: < Lansoprazol-CT and associated names (see Annex I) 30 mg , gastro-resistant capsules, hard > Lansoprazol
Danish: < Lansoprazol-CT og tilknyttede navne (se Bilag I) 30 mg gastro-resistente hårde kapsler > Lansoprazol
English: Germany ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Danish: Tyskland ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Tyskland
English: Finland ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Danish: Finland ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Tyskland
English: < Lansoprazol-CT and associated names (see Annex I) 15 mg , gastro-resistant capsules, hard > Lansoprazol
Danish: < Lansoprazol-CT og tilknyttede navne (se Bilag I) 15 mg gastro-resistente hårde kapsler > Lansoprazol
English: Nervous system disorders Common:
Danish: Forstyrrelser i nervesystemet Almindelig: Hovedpine, svimmelhed Sjælden:
English: headache, dizziness
Danish: Almindelig: Træthed
English: HOW TO TAKE Lansoprazol-CT
Danish: HVORLEDES SKAL Lansoprazol-CT TAGES
English: - if you use Lansoprazol-CT in combination therapy with antibiotics to eradicate Helicobacter pylori, you should carefully read the package leaflets of these antibiotics, too - if you take Lansoprazol-CT for longer than 1 year, therapy should be regularly monitored and the doctor should carefully consider the benefit versus risk ratio - if you experience any problems with your eyesight following long-term use (longer than 1 year), treatment with Lansoprazol-CT should be promptly discontinued and you should consult an ophthalmologist.
Danish: - hvis du oplever nogen problemer med dit syn efter længerevarende brug (længere end 1 år), bør behandlingen med Lansoprazol-CT straks afbrydes, og du bør opsøge en oftalmolog.
English: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-CT and associated names (see Annex I) 30 mg , gastro-resistant capsules, hard > lansoprazole
Danish: LÆGEMIDLETS NAVN < Lansoprazol-CT og tilknyttede navne (se Bilag I) 30 mg gastro-resistent hård kapsel > lansoprazol
English: NAME OF THE MEDICINAL PRODUCT < Lansoprazol-CT and associated names (see Annex I) 15 mg , gastro-resistant capsules, hard > lansoprazole
Danish: LÆGEMIDLETS NAVN < Lansoprazol-CT og tilknyttede navne (se Bilag I) 15 mg gastro-resistent hård kapsel > lansoprazol
English: visual disturbances Hormonal disorders Very rare:
Danish: Palpitationer, brystsmerter Vaskulære forstyrrelser Sjælden:
English: ratiopharm GmbH Graf-Arco-Strasse 3 89079 Ulm Germany
Danish: ratiopharm GmbH Graf-Arco-Strasse 3 D-89079 Ulm Tyskland
English: The recommended dose is 1 capsule once daily (equivalent to 30 mg lansoprazole) for 4 weeks.
Danish: Den anbefalede dosis er 1 kapsel én gang daglig (svarende til 30 mg lansoprazol) i 4 uger.
English: The recommended dose is 2 capsules once daily (equivalent to 30 mg lansoprazole) for 2 weeks.
Danish: Den anbefalede dosis er 2 kapsler én gang daglig (svarende til 30 mg lansoprazol) i 2 uger.
English: The recommended dose is 2 capsules once daily (equivalent to 30 mg lansoprazole) for 4 weeks.
Danish: Den anbefalede dosis er 2 kapsler én gang daglig (svarende til 30 mg lansoprazol) i 4 uger.
English: The recommended dose is 1 capsule once daily (equivalent to 30 mg lansoprazole) for 2 weeks.
Danish: Den anbefalede dosis er 1 kapsel én gang daglig (svarende til 30 mg lansoprazol) i 2 uger.
English: Reassortant influenza virus
Danish: Reassortant influenzavirus
English: 1 After reconstitution, 1 dose (0.2 ml) contains:
Danish: 1 Efter rekonstitution, 1 dosis (0,2 ml) indeholder:
English: 1 (live attenuated) of the following four strains
Danish: 1 (levende svækket) fra følgende fire stammer
English: produced in VERO cells by reverse genetic technology.
Danish: produceret i VERO-celler ved revers genteknologi.
English: propagated in fertilised hens' eggs from healthy chicken flocks.
Danish: formeret i befrugtede hønseæg fra sunde hønsehold.
English: Pack size sprayer (glass) in trays sprayer (glass) in a tri-fold carton
Danish: Pakningsstørrelse spray (glas) i bakker spray (glas) i folde-æske
English: B/Colorado/06/2017 - like strain (B/Colorado/06/2017, MEDI 293454)
Danish: B/Colorado/06/2017 - lignende stamme (B/Colorado/06/2017, MEDI 291690)
English: MA (EU) Number
Danish: MF (EU)-nummer Navn
English: The full EPAR for Flixabi can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Flixabi findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: It is used in adults, usually when other medicines or treatments have failed or cannot be used, for the treatment of the following diseases:
Danish: Det anvendes til voksne, almindeligvis når andre lægemidler eller behandlinger ikke virker eller ikke kan anvendes, til behandling af følgende sygdomme:
English: This is a summary of the European public assessment report (EPAR) for Flixabi.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Flixabi.
English: This means that Flixabi is similar to a biological medicine (also known as the ‘reference medicine') that is already authorised in the European Union (EU).
Danish: Det betyder, at Flixabi svarer til et biologisk lægemiddel (også kaldet "referencelægemidlet"), der allerede er godkendt i Den Europæiske Union (EU).
English: A risk management plan has been developed to ensure that Flixabi is used as safely as possible.
Danish: Der er udarbejdet en risikostyringsplan for at sikre, at Flixabi anvendes så sikkert som muligt.
English: The main measure of effectiveness was the proportion of patients who achieved at least a 20% reduction in ACR scores (a measure of painful, swollen joints and other symptoms) after 30 weeks of treatment.
Danish: Det vigtigste mål for virkningen var den andel af patienterne, der opnåede en reduktion på mindst 20 % i ACR-score (et mål for smertende, hævede led og andre symptomer) efter 30 ugers behandling.
English: Therefore, the CHMP's view was that, as for Remicade, the benefit outweighs the identified risk.
Danish: Det var derfor CHMP's opfattelse, at fordelene opvejer de identificerede risici som for Remicade.
English: Flixabi is given as an infusion lasting one or two hours.
Danish: Flixabi gives som en infusion, der varer 1-2 timer.
English: What measures are being taken to ensure the safe and effective use of Flixabi?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Flixabi?
English: Studies were carried out to show that Flixabi is comparable to Remicade, including a study to show that it produces similar levels of the active substance in the body to Remicade.
Danish: Der blev udført undersøgelser for at vise at Flixabi er sammenligneligt med Remicade, herunder en undersøgelse for at vise at det frembringer samme mængde aktivt stof i kroppen som Remicade.
English: Other information about Flixabi
Danish: Andre oplysninger om Flixabi
English: Results of this study showed that Flixabi was as effective as Remicade in reducing symptoms of rheumatoid arthritis: 64% of those treated with Flixabi (148 of 231 patients) had at least a 20% reduction in ACR scores, compared with 66% of those given Remicade (163 out of 247).
Danish: Denne undersøgelse viste, at Flixabi er lige så effektivt som Remicade til at nedsætte symptomerne på reumatoid artritis: 64 % af dem, der blev behandlet med Flixabi (148 af 231 patienter) havde en reduktion på mindst 20 % i ACR-score sammenlignet med 66 % af dem, der fik Remicade (163 ud af
English: In particular, information will be provided for doctors who intend to prescribe the medicine to children with Crohn's disease or ulcerative colitis, to explain that these patients may be at an increased risk of developing infections and to remind of the importance of keeping vaccinations up to date.
Danish: Dette gælder især oplysninger til de læger, som forventes at ordinere lægemidlet til børn med Crohns sygdom eller ulcerøs kolitis for at gøre opmærksom på, at disse patienter kan have øget risiko for at udvikle infektioner og minde lægerne om vigtigheden af, at barnet har fulgt det gældende vaccinationsprogram.
English: Flixabi is usually given as 3 mg per kilogram body weight in rheumatoid arthritis, although the dose can be increased if necessary.
Danish: Ved reumatoid artritis anvendes Flixabi sædvanligvis i en dosis på 3 mg/kg legemsvægt, dog kan dosis om nødvendigt øges.
English: By blocking TNF-alpha, infliximab improves the inflammation and other symptoms of these diseases.
Danish: Ved at blokere TNF-alpha bedrer infliximab inflammationen og andre symptomer på disse sygdomme.
English: What is Flixabi and what is it used for?
Danish: Hvad er Flixabi, og hvad anvendes det til?
English: To reduce the risk of infusion-related reactions, patients may be given other medicines before or during treatment with Flixabi or the infusion time may be slowed down.
Danish: For at mindske risikoen for bivirkninger ved infusionen kan patienterne få andre lægemidler før eller under behandlingen med Flixabi, eller infusionen gives over længere tid.
English: The most common side effects with Flixabi (seen in more than 1 patient in 10) are viral infections (such as flu or cold sores), headache, upper-respiratory-tract infection (colds), sinusitis (inflammation of the sinuses), nausea (feeling sick), abdominal pain (stomach ache), infusion-related reactions and pain.
Danish: De hyppigste bivirkninger ved Flixabi (som optræder hos flere end 1 ud af 10 patienter) er virusinfektioner (såsom influenza eller forkølelsessår), hovedpine, infektioner i de øvre luftveje (forkølelser), sinusitis (bihulebetændelse), kvalme, mavesmerter, infusionsrelaterede reaktioner og smerter.
English: Flixabi is also used in patients aged between 6 and 17 years with severe Crohn's disease or ulcerative colitis, when they have not responded to or cannot take other medicines or treatments.
Danish: Flixabi anvendes desuden hos patienter mellem 6 og 17 år med svær Crohns sygdom eller ulcerøs kolitis, når andre lægemidler eller behandlinger ikke virker eller ikke kan anvendes.
English: Why is Flixabi approved?
Danish: Hvorfor blev Flixabi godkendt?
English: Flixabi must also not be used in patients with tuberculosis, other severe infections, or moderate or severe heart failure (an inability of the heart to pump enough blood around the body).
Danish: Flixabi må heller ikke anvendes til patienter med tuberkulose, andre svære infektioner eller moderat til svær hjerteinsufficiens (hjertets manglende evne til at pumpe tilstrækkeligt blod rundt i kroppen).
English: What are the risks associated with Flixabi?
Danish: Hvilke risici er der forbundet med Flixabi?
English: The reference medicine for Flixabi is Remicade.
Danish: Referencelægemidlet for Flixabi er Remicade.
English: Flixabi was also compared with Remicade in one main study involving 584 patients with moderate to severe rheumatoid arthritis who had received previous treatment with methotrexate.
Danish: Flixabi blev desuden sammenlignet med Remicade i en hovedundersøgelse med 584 patienter med moderat til svær reumatoid artritis, som tidligere havde modtaget behandling med methotrexat.
English: Flixabi is an anti-inflammatory medicine.
Danish: Flixabi er et antiinflammatorisk lægemiddel.
English: The active substance in Flixabi, infliximab, is a monoclonal antibody (a type of protein) that has been designed to attach to a protein called tumour necrosis factor-alpha (TNF-alpha) and block its activity.
Danish: Det aktive stof i Flixabi, infliximab, er et monoklonalt antistof (en type protein), der er opbygget, så det binder til et protein, der kaldes tumornekrosefaktor-alfa (TNF-alfa) og blokerer dets aktivitet.
English: Flixabi contains the active substance infliximab and is a ‘biosimilar medicine'.
Danish: Flixabi indeholder det aktive stof infliximab og er et "biosimilært lægemiddel".
English: Flixabi treatment should be started and supervised by a specialist doctor who has experience in the diagnosis and treatment of the diseases that Flixabi is used to treat.
Danish: Behandling med Flixabi bør iværksættes og overvåges af en speciallæge med erfaring i diagnose og behandling af de sygdomme, Flixabi anvendes til.
English: It is not intended to provide practical advice on how to use Flixabi.
Danish: Det er ikke en praktisk vejledning i, hvordan Flixabi bør anvendes.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Flixabi, including the appropriate precautions to be followed by healthcare professionals and patients.
Danish: På baggrund af denne er der anført sikkerhedsoplysninger i produktresuméet og indlægssedlen for Flixabi, herunder passende forholdsregler, som patienter og sundhedspersonale skal følge.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that Flixabi has been shown to have a comparable quality, safety and effectiveness to Remicade.
Danish: Agenturets Udvalg for Lægemidler til Mennesker (CHMP) konkluderede, at det er påvist, at Flixabi og Remicades kvalitet, sikkerhed og virkning svarer til hinanden.
English: For more information about treatment with Flixabi, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Flixabi, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: In addition, the company that markets Flixabi will provide an alert card for patients and educational material for prescribers, summarising the safety information about the medicine.
Danish: Desuden skal den virksomhed, der markedsfører Flixabi, udlevere et advarselskort til patienterne og oplysningsmateriale til de læger, som forventes at ordinere lægemidlet, der opsummerer lægemidlets sikkerhedsoplysninger.
English: Flixabi is used with methotrexate (a medicine that acts on the immune system);
Danish: Flixabi anvendes sammen med methotrexat (et lægemiddel, der virker på immunsystemet)
English: Flixabi must not be used in patients who are hypersensitive (allergic) to infliximab, mouse proteins or any of the other ingredients of Flixabi.
Danish: Flixabi må ikke anvendes til patienter, der er overfølsomme (allergiske) over for infliximab, museproteiner eller andre af indholdsstofferne i Flixabi.
English: • Crohn's disease (a disease causing inflammation of the gut), when the disease is moderate to severe or causes fistulae (abnormal passageways between the gut and other organs);
Danish: • Crohns sygdom (en sygdom, der medfører inflammation af fordøjelseskanalen), når sygdommen er moderat til svær eller har medført dannelse af fistler (abnorme passager mellem tarmen og andre organer)
English: The Committee recommended that Flixabi be given marketing authorisation.
Danish: Udvalget anbefalede udstedelse af markedsføringstilladelse for Flixabi.
English: For the full list of all side effects reported with Flixabi, see the package leaflet.
Danish: Den fuldstændige liste over alle de indberettede bivirkninger ved Flixabi fremgår af indlægssedlen.
English: For further information see the summary of product characteristics (also part of the EPAR).
Danish: De nærmere oplysninger fremgår af produktresuméet, der ligeledes er en del af denne EPAR.
English: TNF-alpha is involved in causing inflammation and is found at high levels in patients with the diseases that Flixabi is used to treat.
Danish: TNFalpha er en medvirkende årsag til betændelsestilstande og findes i høje koncentrationer hos patienter med de sygdomme, der behandles med Flixabi.
English: For practical information about using Flixabi, patients should read the package leaflet or contact their doctor or pharmacist.
Danish: Hvis du ønsker praktisk vejledning om anvendelsen af Flixabi, kan du læse indlægssedlen eller kontakte din læge eller dit apotek.
English: What benefits of Flixabi have been shown in studies?
Danish: Hvilke fordele viser undersøgelserne, at der er ved Flixabi?
English: How does Flixabi work?
Danish: Hvordan virker Flixabi?